Deepak Bhatt, MD, MPH

Articles by Deepak Bhatt, MD, MPH

Updated ACC/AHA Dyslipidemia Guidelines Incorporate LDL-C Goals, Lp(a) Focus, With Deepak Bhatt, MD, MPH

March 25th 2026

Bhatt shares his thoughts on the recently released dyslipidemia guidelines, highlighting the return of goal-based LDL-C therapy and Lp(a) receiving a COR 1 suggestion.

RSV Vaccine Demonstrates Cardioprotective Effects, Reduces MACE and Hospitalizations, With Deepak Bhatt, MD, MPH

ByDeepak Bhatt, MD, MPH

February 26th 2026

Bhatt discusses a recent study from GSK highlighting AREXVY’s efficacy in lowering major adverse cardiovascular events.

Deepak Bhatt, MD | Image Credit: Mount Sinai

TRANQUILITY: Pacibekitug Safely Lowers hs-CRP in ASCVD, With Deepak Bhatt, MD

ByDeepak Bhatt, MD, MPH

November 20th 2025

Bhatt discusses the positive results from the phase 2 trial of quarterly and monthly doses of investigational IL-6 inhibitor pacibekitug.

ACC 2025 Clinical Trials to Watch with Deepak Bhatt, MD, MPH, MBA

ByDeepak Bhatt, MD, MPH

March 21st 2025

Bhatt previews 3 late-breaking clinical trials being presented at this year's American College of Cardiology Annual Scientific Sessions.

Concluding Thoughts

ByDeepak Bhatt, MD, MPH,Marc P. Bonaca, MD, MPH,Sahil Parikh, MD,Eric Secemsky, MD,Amy Pollak, MD,Manesh Patel, MD

June 10th 2022

A panel of expert cardiologists share their concluding thoughts on management of polyvascular disease in clinical practice.

Unmet Needs and Emerging Approaches to Management of Polyvascular Disease

ByDeepak Bhatt, MD, MPH,Marc P. Bonaca, MD, MPH,Sahil Parikh, MD,Eric Secemsky, MD,Amy Pollak, MD,Manesh Patel, MD

June 10th 2022

Cardiologists share unmet needs and emerging approaches to management of patients with polyvascular disease.

VOYAGER Trial and DPI in Clinical Practice

ByDeepak Bhatt, MD, MPH,Marc P. Bonaca, MD, MPH,Sahil Parikh, MD,Eric Secemsky, MD,Amy Pollak, MD,Manesh Patel, MD

June 10th 2022

Manesh Patel, MD, reviews VOYAGER trial data and expert cardiologists share where they use DPI [dual pathway inhibition] in their practices.

COMPASS Trial for CAD and PAD

ByDeepak Bhatt, MD, MPH,Marc P. Bonaca, MD, MPH,Sahil Parikh, MD,Eric Secemsky, MD,Amy Pollak, MD,Manesh Patel, MD

June 3rd 2022

Expert cardiologists discuss data from COMPASS trial and the role of rivaroxaban and low-dose aspirin in treatment of patients with CAD and PAD.

Access to and Awareness of DPI for Polyvascular Disease

ByDeepak Bhatt, MD, MPH,Marc P. Bonaca, MD, MPH,Sahil Parikh, MD,Eric Secemsky, MD,Amy Pollak, MD,Manesh Patel, MD

June 3rd 2022

Sahil Parikh, MD, shares how lack of access to or awareness of DPI [dual pathway inhibition] causes many practices and health care providers to face a challenge in treating CAD [coronary artery disease].

Direct Oral Anticoagulants and Dosing

ByDeepak Bhatt, MD, MPH,Marc P. Bonaca, MD, MPH,Sahil Parikh, MD,Eric Secemsky, MD,Amy Pollak, MD,Manesh Patel, MD

May 27th 2022

Drs Patel and Bhatt discuss importance of correct dosing of direct oral anticoagulants in treatment of cardiovascular diseases.

Dual Pathway Inhibition in Coronary Artery Disease

ByDeepak Bhatt, MD, MPH,Marc P. Bonaca, MD, MPH,Sahil Parikh, MD,Eric Secemsky, MD,Amy Pollak, MD,Manesh Patel, MD

May 27th 2022

Expert cardiologists provide an overview of dual pathway inhibition, modulation of thrombotic risk and treatment of CAD.

Risk-Benefit Analysis in Treatment Selection in CAD

ByDeepak Bhatt, MD, MPH,Marc P. Bonaca, MD, MPH,Sahil Parikh, MD,Eric Secemsky, MD,Amy Pollak, MD,Manesh Patel, MD

May 20th 2022

Dr Amy Pollak shares her thoughts on risk-benefit analysis when evaluating patients with high thrombotic/bleeding risk and treatment selection.

Stents in Treatment of CAD and PAD

ByDeepak Bhatt, MD, MPH,Marc P. Bonaca, MD, MPH,Sahil Parikh, MD,Eric Secemsky, MD,Amy Pollak, MD,Manesh Patel, MD

May 20th 2022

Dr Eric Secemsky discusses how use of stents has evolved over the years in treatment of polyvascular disease.

Dual Antiplatelet Therapy in CAD

ByDeepak Bhatt, MD, MPH,Marc P. Bonaca, MD, MPH,Sahil Parikh, MD,Eric Secemsky, MD,Amy Pollak, MD,Manesh Patel, MD

May 13th 2022

Dr Manesh Patel and other experts discuss the role of dual antiplatelet therapy (DAPT) in treatment of coronary artery disease.

Regimen Intensification in Polyvascular Disease

ByDeepak Bhatt, MD, MPH,Marc P. Bonaca, MD, MPH,Sahil Parikh, MD,Eric Secemsky, MD,Amy Pollak, MD,Manesh Patel, MD

May 13th 2022

Drs Marc Bonaca and Deepak Bhatt discuss the role of therapy intensification when managing high-risk patients with polyvascular disease.

Guidelines and Management of Patients With Polyvascular Disease

ByDeepak Bhatt, MD, MPH,Marc P. Bonaca, MD, MPH,Sahil Parikh, MD,Eric Secemsky, MD,Amy Pollak, MD,Manesh Patel, MD

May 6th 2022

Expert cardiologists discuss CAD guidelines and approaches to management of patients with polyvascular disease.

Provider Engagement and Screening

ByDeepak Bhatt, MD, MPH,Marc P. Bonaca, MD, MPH,Sahil Parikh, MD,Eric Secemsky, MD,Amy Pollak, MD,Manesh Patel, MD

May 6th 2022

Dr Sahil Parikh and other experts discuss engagement of cardiologists in patients diagnosed with polyvascular disease and challenges in screening patients.